Related Experiment Video
Updated: Jun 3, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Canadian paediatricians' opinions on rotavirus vaccination
1Institut national de santé publique du Québec, 2400 d'Estimauville, Québec, Québec, Canada. eve.dube@ssss.gouv.qc.ca
Insights
Pediatricians in Canada view rotavirus disease as a significant health and economic burden, yet their intention to recommend rotavirus vaccines remains low, impacting vaccine uptake.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
- Public Health Policy
Background:
- Rotavirus is a primary cause of severe gastroenteritis and hospitalization in young children globally.
- Two safe and effective rotavirus vaccines are available but not publicly funded in Canada.
- Understanding healthcare provider perspectives is crucial for vaccine implementation.
Purpose of the Study:
- To assess Canadian pediatricians' knowledge, attitudes, and beliefs (KAB) regarding rotavirus disease and vaccination.
- To identify factors influencing pediatricians' intention to recommend rotavirus vaccines.
- To evaluate the potential impact of public funding on vaccine uptake.
Main Methods:
- Anonymous, self-administered questionnaire based on the Health Belief Model and immunization program frameworks.
- Mailed survey to 1852 Canadian pediatricians, achieving a 50% response rate.
- Multivariate analysis to determine key predictors of recommendation intention.
Main Results:
- Most pediatricians perceived rotavirus disease as moderately consequential and a significant economic burden.
- 69% considered rotavirus vaccines safe; 61% considered them effective.
- Perceived disease burden strongly predicted intention to recommend (R²=0.49, p<0.0001), while adverse event risk was a key barrier.
Conclusions:
- While over half of pediatricians are willing to recommend rotavirus vaccines, strong intention is low compared to other vaccines.
- Low uptake is anticipated without public funding, mirroring challenges with other new vaccines.
- Addressing perceived barriers and highlighting disease burden are key for improving rotavirus vaccine recommendation rates.
Abstract:
Rotavirus is the leading cause of dehydration and hospitalization due to gastroenteritis (GE) in young children. Almost all children are affected by the age of 5 years. Two safe and effective rotavirus vaccines are available for clinical use in Canada. In the context where rotavirus vaccination is recommended, but not publicly funded, we have assessed paediatricians' knowledge, attitudes and beliefs (KAB) regarding rotavirus disease and its prevention by vaccination. A self-administered anonymous questionnaire based upon the Health Belief Model and the Analytical framework for immunization programs was mailed to all 1852 Canadian paediatricians. The response rate was 50%. The majority of respondents rated consequences of rotavirus infection for young patients as moderate. Sixty-six percent considered that rotavirus disease occur frequently without vaccination and 62% estimated that the disease generates a significant economic burden. Sixty-nine percent of respondents considered rotavirus vaccines to be safe and 61%, to be effective. The reduction of severe GE cases was seen as the main benefit of rotavirus vaccination, while the risk of adverse events was the principal perceived barrier. Fifty-three percent (53%) indicated a strong intention to recommend rotavirus vaccines. In multivariate analysis, main determinant of paediatricians' intention to recommend rotavirus vaccines was the perceived health and economic burden of rotavirus diseases (partial R(2)=0.49, p<0.0001). More than half of surveyed paediatricians were willing to recommend rotavirus vaccines to their patients, but the proportion of respondents who had a strong intention to do so remains low when compared to several other new vaccines. As with other new vaccines, rotavirus vaccine uptake risks to remain low in Canada as long as it is not publicly funded.
Related Concept Videos
Poliomyelitis
Vaccinations
Respiratory Syncytial Virus Disease
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism

